An Update of Outcome Measures in Systemic Sclerosis
Authors:
Open Access
- 22 October 2020
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 72 (S10) , 110-133
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)Clinical Rheumatology, 2013
- Evaluation of Test Characteristics for Outcome Measures Used in Raynaud's Phenomenon Clinical TrialsArthritis Care & Research, 2012
- Validity of two new patient‐reported outcome measures in systemic sclerosis: Patient‐reported outcomes measurement information system 29‐item health profile and functional assessment of chronic illness therapy–dyspnea short formArthritis Care & Research, 2011
- Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentThe Journal of Rheumatology, 2011
- Development and validation of the brief‐satisfaction with appearance scale for systemic sclerosisArthritis Care & Research, 2010
- The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trialAnnals of the Rheumatic Diseases, 2010
- Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scaleAnnals of the Rheumatic Diseases, 2007
- Assessing body image in patients with systemic sclerosis (scleroderma): Validation of the Adapted Satisfaction with Appearance ScaleBody Image, 2007
- Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosisRheumatology, 2006
- European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteriaAnnals of the Rheumatic Diseases, 2003